These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29100525)

  • 1. Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity.
    Bobela W; Nazeeruddin S; Knott G; Aebischer P; Schneider BL
    Mol Neurodegener; 2017 Nov; 12(1):80. PubMed ID: 29100525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein.
    Ciron C; Zheng L; Bobela W; Knott GW; Leone TC; Kelly DP; Schneider BL
    Acta Neuropathol Commun; 2015 Apr; 3():16. PubMed ID: 25853296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
    Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
    Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.
    Dulovic M; Jovanovic M; Xilouri M; Stefanis L; Harhaji-Trajkovic L; Kravic-Stevovic T; Paunovic V; Ardah MT; El-Agnaf OM; Kostic V; Markovic I; Trajkovic V
    Neurobiol Dis; 2014 Mar; 63():1-11. PubMed ID: 24269733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
    Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
    Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions.
    Anandhan A; Lei S; Levytskyy R; Pappa A; Panayiotidis MI; Cerny RL; Khalimonchuk O; Powers R; Franco R
    Mol Neurobiol; 2017 Jul; 54(5):3825-3842. PubMed ID: 27324791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein binds and sequesters PIKE-L into Lewy bodies, triggering dopaminergic cell death via AMPK hyperactivation.
    Kang SS; Zhang Z; Liu X; Manfredsson FP; He L; Iuvone PM; Cao X; Sun YE; Jin L; Ye K
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1183-1188. PubMed ID: 28096359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.
    Bobela W; Aebischer P; Schneider BL
    Biomolecules; 2015 Oct; 5(4):2675-700. PubMed ID: 26501339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methanolic Extract of Boswellia serrata Gum Protects the Nigral Dopaminergic Neurons from Rotenone-Induced Neurotoxicity.
    Shadfar S; Khanal S; Bohara G; Kim G; Sadigh-Eteghad S; Ghavami S; Choi H; Choi DY
    Mol Neurobiol; 2022 Sep; 59(9):5874-5890. PubMed ID: 35804280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.
    Anandhan A; Rodriguez-Rocha H; Bohovych I; Griggs AM; Zavala-Flores L; Reyes-Reyes EM; Seravalli J; Stanciu LA; Lee J; Rochet JC; Khalimonchuk O; Franco R
    Neurobiol Dis; 2015 Sep; 81():76-92. PubMed ID: 25497688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
    Caudal D; Alvarsson A; Björklund A; Svenningsson P
    Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease.
    Curry DW; Stutz B; Andrews ZB; Elsworth JD
    J Parkinsons Dis; 2018; 8(2):161-181. PubMed ID: 29614701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
    Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
    Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sestrin2 Protects Dopaminergic Cells against Rotenone Toxicity through AMPK-Dependent Autophagy Activation.
    Hou YS; Guan JJ; Xu HD; Wu F; Sheng R; Qin ZH
    Mol Cell Biol; 2015 Aug; 35(16):2740-51. PubMed ID: 26031332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stress-enhanced model for discovery of disease-modifying gene: Ece1-suppresses the toxicity of α-synuclein A30P.
    Chen AY; Tully T
    Neurobiol Dis; 2018 Jun; 114():153-163. PubMed ID: 29524599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emotional memory impairments induced by AAV-mediated overexpression of human α-synuclein in dopaminergic neurons of the ventral tegmental area.
    Alvarsson A; Caudal D; Björklund A; Svenningsson P
    Behav Brain Res; 2016 Jan; 296():129-133. PubMed ID: 26341317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.